CME Webcast Teaches on Pregnancy and Heart Disease

OSUWexnerbloglogo2014 CME Webcast Teaches on Pregnancy and Heart Disease. During this webcast, we are going to see how each of us can help prevent cardiac complications during and after pregnancy. Joining me is Assistant Professor of Cardiology from the Ohio State University, Dr. Lauren Lastinger.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Review the spectrum of heart disease in pregnancy and how it is managed; and define trends in maternal mortality in the USA and discuss strategies for providers to improve maternal mortality.

You’ll also learn about the following:

  • Cardio-obstetrics
  • Common cardiac conditions in pregnancy
  • Accurate blood pressure measurements during pregnancy
  • Exercise for pregnant women with heart disease
  • Coronary disease and pregnancy
  • Heart transplant patients and pregnancy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Experts Discuss Genetic Disease Update on Webcast

OSUWexnerbloglogo2014 Experts Discuss Genetic Disease Update on Webcast. On this CME webcast, we’re going to get an update on how clinical genetics is improving the outcomes and survival of patients with breast cancer and heart failure. We’re pleased to welcome this week’s guests. Kevin Sweet is a genetics counselor and Professor in the Department of Internal Medicine and he is going to discuss breast cancer genetics. And Elizabeth Jordan is a genetics counselor and Assistant Professor of Internal Medicine who will be talking about the genetics of cardiomyopathy.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: define hereditary breast ovarian cancer syndrome; provide a case example of genetic/genomic testing and management of a patient and family with hereditary breast ovarian cancer syndrome; describe the current state of the genetics of dilated cardiomyopathy (DCM), including (1) list clinically relevant DCM genes, (2) outline the Genetic Testing process for DCM, and (3) discuss the guidelines for the family-based genetic evaluation of cardiomyopathy; explore a genetic DCM case example; and consider future directions of DCM genetics.

You’ll also learn about the following:

  • Epidemiology of inherited breast cancer
  • Epidemiology of inherited cardiomyopathy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Latest Discoveries in Alzheimer’s Disease on CME Webcast

OSUWexnerbloglogo2014 Learn About Latest Discoveries in Alzheimer’s Disease on CME Webcast. 120 years ago, when Dr. Alzheimer first started taking care of Auguste Deter, there was no treatment for her condition. But now, medical research has brought us new treatments with hope for some patients who previously had no hope. On this CME webcast, we are going to hear about some of this research and some of these new treatments. We’re pleased to welcome Assistant Professor of Neurology, Dr. Rawan Tarawneh.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Understand the pathology of Alzheimer disease, including the clinical and pathological heterogeneity and the importance of biomarkers for an accurate diagnosis; Learn about the new FDA-approved anti-amyloid agent aducanumab (approved June 2021).

You’ll also learn about the following:

  • Etiology of Alzheimer’s Disease
  • Alzheimer’s Disease treatments
  • Concerns regarding aducanumab
  • Identifying patients with Alzheimer’s disease in the primary care office
  • Diet and lifestyle measures
  • Managing insomnia

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Webcast Helps Physicians Learn About Ocular Complications of Systemic Disease

OSUWexnerbloglogo2014 Webcast Helps Physicians Learn About Ocular Complications of Systemic Disease. It has been said that the eyes are the windows to the soul. That may or may not be true but the eyes can be the windows to disease. Sometimes, it is the ocular findings that are the first clue to an underlying systemic disease. Other times, a known systemic disease may alert the physician about the risks of important ocular complications. The ophthalmoscope allows you to examine structures you can’t otherwise see. For example, the retinal arteries are the only arteries that are easily visible non-invasively. Today on MedNet21, we’re going to see how the eye can be affected by many common systemic diseases. My guest is Assistant Professor of Ophthalmology, Dr. Carla Ford.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: discuss ocular findings
of common systemic diseases; and provide a brief overview of treatment options of ocular complications of systemic diseases.

You’ll also learn about the following:

  • Common systemic diseases affecting the eye
  • Central retinal vein occlusion
  • Migraine and the eye
  • Candidemia
  • HIV and the eye

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webast Teaches On Chronic Kidney Disease

OSUWexnerbloglogo2014 CME Webast Teaches On Chronic Kidney Disease. Now, dialysis has become so commonplace that we now consider it to be a routine treatment in nearly every hospital in the country. But more importantly, we now have treatments that can hold kidney failure in check and often prevent the need for dialysis. Today on MedNet, we are going to take a look at some of these new developments in the management of chronic kidney disease. I’m please to introduce today’s guest. Dr. Khaled Boubes is nephrologist and Assistant Professor of Internal Medicine at the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: recognize the prevalence and importance of CKD; and realize the importance and effectiveness of SGLT2-inhibitors in halting the progression of CKD.

You’ll also learn about the following:

  • Causes of chronic kidney disease
  • New treatments for chronic kidney disease
  • Diet and chronic kidney disease
  • Blood pressure management in chronic kidney disease
  • Anti-hypertensive medication selection in chronic kidney disease
  • Acute dialysis indications
  • Chronic dialysis indications
  • Options for dialysis

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.